Project Grant HT94252510138
Award Date
7/1/25
Completion Date
6/30/29
Dollars Obligated
$5.1M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Seattle, WA 98109, USA
Similar Awards
The federal Project Grant award of $2,288,000.00 was issued by the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to the Fred Hutchinson Cancer Center in Seattle, Washington. The award supports advanced biomedical research focused on transforming healthcare for military service members and the general public, with a specific focus on targeting epidermal plasticity to prevent triple negative breast cancer. The research will be...
The Defense Health Agency awarded a $528,000 Project Grant to the Fred Hutchinson Cancer Center, doing business as the Seattle Cancer Care Alliance, to assess the landscape of cell surface targets in metastatic prostate cancer. This 2-year grant, which began on April 15, 2024, is funded through the Military Medical Research and Development program (CFDA 12.420). The project aims to advance biomedical research on innovative therapeutic approaches for cancer, in line with the program's goals of...
The federal Project Grant award of $1,578,836.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports the Fred Hutchinson Cancer Center (doing business as Seattle Cancer Care Alliance) in developing and exploiting a third-generation prostate cancer dependency map to identify cancer vulnerabilities and treatment targets. The award, which runs from August 1, 2024 to July 31, 2027, will enable the research organization to conduct innovative...
The federal Project Grant award, ID HT94252411040, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The $879,692 award, with a performance period from September 30, 2024 to September 29, 2027, supports the Fred Hutchinson Cancer Center's research on "Combinatorial Phenotype-Targeted Therapy to Overcome Mechanisms Driving Prostate Cancer Treatment Resistance." This innovative research project aims to develop novel...
The Fred Hutchinson Cancer Research Center was awarded a $1,125,843 Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420) for the period of August 1, 2021 through July 31, 2024. Under this award, Fred Hutchinson Cancer Research Center will define and modulate BRCANESS to improve the precision of prostate cancer therapy. The Military Medical Research and Development program supports biomedical research to transform military...
This $175,978 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) is funding research by the Fred Hutchinson Cancer Center, doing business as the Seattle Cancer Care Alliance, to study the role of ARID1A mutations in intrahepatic cholangiocarcinoma. The award period is from August 1, 2024 to July 31, 2026. The funding will support the organization's biomedical research and provision of medical care services related to...
The Fred Hutchinson Cancer Center was awarded a $1.32 million Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The three-year award will support prostate cancer research from July 1, 2022 to June 30, 2025. Through this funding, Fred Hutchinson Cancer Center will conduct basic, applied, and advanced biomedical research to develop new medical solutions for prostate cancer. The Military Medical Research and...
Fred Hutchinson Cancer Center was awarded a $898,342 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from July 1, 2023 to June 30, 2026 to exploit real-world clinical genomic data to discover biomarkers and address outcome disparity for prostate cancer. Through this award, Fred Hutchinson Cancer Center will leverage existing genomic and clinical data to identify biomarkers...
This federal Project Grant award in the amount of $1,927,373.00 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The grant supports research to develop targeted therapies for metastatic prostate cancers classified by subtypes of DNA repair deficiency. The primary awardee is the Fred Hutchinson Cancer Center, a prominent non-profit medical research organization located in Seattle, Washington. The grant has a performance...
The Department of the Army Medical Command awarded a $1,275,000 project grant under the Military Medical Research and Development (CFDA 12.420) program to the Fred Hutchinson Cancer Center in Seattle, Washington. The purpose of this 4-year grant, awarded on November 1, 2024, is to develop a centralized resource that will engage key stakeholders involved in rare tumors of the liver, including oncologists, pathologists, researchers, and patients. The grant will establish a bioresource that...